FIELD: oncology. SUBSTANCE: over the first two years after radical operative intervention, histological investigations of tumors are performed and percentage of proliferating mammary gland cancer cells is estimated using monoclonal antibodies to proliferating nuclear proteins. From the level of proliferative activity, one can estimate probability of generalization of process for each patient. This method makes possible prediction of probability of fast generalization of process in primary mammary gland cancer patients in the very beginning of treatment in combination with clinicomorphologic parameters. EFFECT: enabled choice of most adequate tactics for treating patients from above-defined group and so enhanced therapeutic efficiency. 1 dwg, 2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF TREATING EARLY BREAST CANCER | 2014 |
|
RU2554749C1 |
METHOD FOR PREDICTING THE COURSE OF A PATHOLOGICAL PROCESS IN LUMINAL NON-HYPEREXPRESSION OF Her2Neu PRIMARY OPERABLE BREAST CANCER IN POSTMENOPAUSAL WOMEN | 2018 |
|
RU2694843C1 |
METHOD TO TREAT MAMMARY GLAND CANCER | 1993 |
|
RU2077268C1 |
BREAST CANCER OUTCOME PREDICTION METHOD | 2008 |
|
RU2361222C1 |
METHOD FOR PREDICTING RISK OF BREAST CANCER PROGRESSION WITH UNDERLYING TAMOXIFEN TAKING INTO ACCOUNT EXPRESSION CHARACTERISTICS OF TUMOUR | 2023 |
|
RU2823488C1 |
METHOD OF ESTIMATION OF ANGIOGENIC FACTORS AT CHEMOTHERAPY OF CANCER OF MAMMARY GLAND | 2006 |
|
RU2341198C2 |
METHOD FOR TREATING MAMMARY GLAND CARCINOMA | 1995 |
|
RU2111707C1 |
METHOD OF PREDICTING RESISTANCE TO NEOADJUVANT CHEMOTHERAPY IN PATIENTS WITH BREAST CANCER | 2022 |
|
RU2802671C1 |
METHOD FOR PREDICTION OF HORMONE-DEPENDENT BREAST CANCER | 2014 |
|
RU2559152C1 |
METHOD FOR PREDICTING NON-METASTATIC SURVIVAL IN PATIENTS WITH BREAST CANCER ON THE BASIS OF EXPRESSION OF SOMATIC-STEM TRANSITION GENES IN RESIDUAL TUMOR AFTER PRE-OPERATIVE TREATMENT | 2018 |
|
RU2682879C1 |
Authors
Dates
1999-04-20—Published
1997-07-22—Filed